On the 80th anniversary of academician of the Russian academy of sciences Sergey Borisovich Seredenin
Psychopharmacology and Addiction Biology · 26.06.2026 · 17 (2) · 119-127
DOI: 10.17816/phbn707500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychopharmacology and Addiction Biology, online erschienen am 26.06.2026. Verfasst von Elena A. Valdman. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Sergey Borisovich Seredenin is an outstanding Russian scientist who has made a significant contribution to the development of fundamental and applied pharmacology. His scientific path is closely connected with the creation of an experimental pharmacogenetic methodology and the development, on its basis, of agents for the pharmacological correction of anxiety-depressive disorders and neurodegenerative diseases. Studies under the supervision of S. B. Seredenin began in the 1970s, when the concept of genetic control of fear reactions was only beginning to take shape. Under his supervision, a system of experimental models was developed and introduced into research practice for the first time, making it possible to study stress-response characteristics in inbred and hybrid laboratory animals. It was these studies that contributed to the understanding that the effect of anxiolytics depends on a genetically determined behavioral phenotype. This relationship proved to be universal, was traced across different animal species, and was subsequently confirmed in humans. The scientific concept of the dependence of pharmacological effects on the phenotype of the response to emotional stress formed the basis of new approaches to the individualization of therapy with neurotropic agents. It was in the studies conducted under the supervision of S. B. Seredenin that the need to consider the stress-response phenotype when choosing treatment tactics was substantiated. This approach is especially important for the medicine of extreme conditions, military and aerospace medicine, where it is necessary to ensure the efficacy of psychotropic therapy without pronounced adverse and side effects. S. B. Seredenin is also known as an organizer of science. For 50 years, he headed the laboratory of pharmacological genetics, and for 25 years he led the V. V. Zakusov Research Institute of Pharmacology. In addition, Sergey Borisovich created a scientific school that has trained a whole galaxy of talented specialists; interdisciplinary research has been carried out with his direct involvement, and international scientific projects have been organized. Under the supervision of S. B. Seredenin, widely used drugs have been introduced into medical practice: Afobazol, Noopept, Selank, and Rankvilon. For outstanding achievements in science, S. B. Seredenin was awarded State Prizes of the USSR and the Russian Federation, received high departmental and state awards, and was elected an academician of the Russian Academy of Sciences. His contribution to the development of Russian and world pharmacology can rightly be considered unique. Colleagues and associates sincerely congratulate Sergey Borisovich on his anniversary!
Zitieren
APA
Valdman, E. A. (2026). On the 80th anniversary of academician of the Russian academy of sciences Sergey Borisovich Seredenin. Psychopharmacology and Addiction Biology, 17(2), 119-127. https://doi.org/10.17816/phbn707500
Vancouver
Valdman EA. On the 80th anniversary of academician of the Russian academy of sciences Sergey Borisovich Seredenin. Psychopharmacology and Addiction Biology. 2026;17(2):119-127. doi:10.17816/phbn707500
BibTeX
@article{Valdman2026,
author = {Valdman, Elena A.},
title = {On the 80th anniversary of academician of the Russian academy of sciences Sergey Borisovich Seredenin},
journal = {Psychopharmacology and Addiction Biology},
year = {2026},
volume = {17},
number = {2},
pages = {119--127},
doi = {10.17816/phbn707500}
}
EUVIMED